PTCT- Ptc Therapeutics, Inc.

Name: Ptc Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Klein Matthew B.	394.1K	$32.63M	-
VP	Boulding Mark Elliott	113.7K	$9.42M	-10,462
CFO	Gravier Pierre	90.3K	$7.48M	-
Other	Pauwels Eric	80.1K	$6.64M	-
VP	Golden Lee Scott	79.1K	$6.55M	-

Activity

Buys and sells only

Transactions

10 filings · page 23

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jul 7, 2020	Boulding Mark Elliott55	Exec. VP And CLO	Sale+OE	30,625	$55.12	$1,688,036.59	-3.5%
Jul 6, 2020	Utter Christine Marie58	SVP, Finance &CAO	Sale+OE	3,288	$53.70	$176,564.24	-10.1%
Jun 29, 2020	Hill Emily Luisa62	Chief Financial Officer	Sell	2,581	$52.50	$135,502.50	-15.9%
Jun 11, 2020	Svoronos Dawn	Director	Sell	364	$48.36	$17,603.04	-1.4%
May 20, 2020	Peltz Stuart Walter57	Chief Executive Officer	Sale+OE	33,788	$50.00	$1,689,400.00	-37.6%
May 18, 2020	Peltz Stuart Walter57	Chief Executive Officer	Sale+OE	6,284	$50.12	$314,979.22	-10.1%
May 5, 2020	Peltz Stuart Walter57	Chief Executive Officer	Sale+OE	109,928	$50.34	$5,533,592.28	-49.1%
Apr 20, 2020	Jacobson Allan Steven51	Director	Sale+OE	20,000	$50.94	$1,018,889.81	-31.3%
Apr 17, 2020	Utter Christine Marie58	SVP, Finance &CAO	Sale+OE	2,145	$50.00	$107,250.00	-18.7%
Apr 3, 2020	Utter Christine Marie58	SVP, Finance &CAO	Sale+OE	787	$44.31	$34,871.97	-7.8%

← PrevPage 23Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC